Ectopic mineralization disorders of the extracellular matrix of connective tissue: Molecular genetics and pathomechanisms of aberrant calcification

Matrix Biology

Volumn 33, Issue , 2014, Pages 23-28

  Li, Qiaoli ^a   Jiang, Qiujie ^a   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Ectopic mineralization; GACI; Generalized arterial calcification of infancy; Heritable connective tissue diseases; MGP; Pathomechanisms of mineralization disorders; Pseudoxanthoma elasticum; PXE

Indexed keywords

ECTOPIC MINERALIZATION; GENERALIZED ARTERIAL CALCIFICATION OF INFANCY; HERITABLE CONNECTIVE TISSUE DISEASES; PATHOMECHANISMS OF MINERALIZATION DISORDERS; PSEUDOXANTHOMA ELASTICUM;

ANIMALS; ARTERIES; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PSEUDOXANTHOMA ELASTICUM; SKIN; VASCULAR CALCIFICATION;

EID: 84894251266     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.06.003     Document Type: Review

References (65)

1. Belinsky M.G., Kruh G.D. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br. J. Cancer 1999, 80:1342-1349.
2. Benet-Pages A., Orlik P., Strom T.M., Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum. Mol. Genet. 2005, 14:385-390.
3. Berkner K.L. The vitamin K-dependent carboxylase. Annu. Rev. Nutr. 2005, 25:127-149.
4. Borst P., van de Wetering K., Schlingemann R. Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery?. Cell Cycle 2008, 7:1575-1579.
5. Brampton C., Yamaguchi Y., Vanakker O., Van Laer L., Chen L.H., Thakore M., De Paepe A., Pomozi V., Szabo P.T., Martin L., Varadi A., Le Saux O. Vitamin K does not prevent soft tissue mineralization in a mouse model of pseudoxanthoma elasticum. Cell Cycle 2011, 10:1810-1820.
6. Budoff M.J., Shaw L.J., Liu S.T., Weinstein S.R., Mosler T.P., Tseng P.H., Flores F.R., Callister T.Q., Raggi P., Berman D.S. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J. Am. Coll. Cardiol. 2007, 49:1860-1870.
7. Chander S., Gordon P. Soft tissue and subcutaneous calcification in connective tissue diseases. Curr. Opin. Rheumatol. 2012, 24:158-164.
8. Daoussis D., Antonopoulos I., Liossis S.N., Yiannopoulos G., Andonopoulos A.P. Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature. Semin. Arthritis Rheum. 2012, 41:822-829.
9. Edouard T., Chabot G., Miro J., Buhas D.C., Nitschke Y., Lapierre C., Rutsch F., Alos N. Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. Eur. J. Pediatr. 2011, 170:1585-1590.
10. Finger R.P., Charbel Issa P., Hendig D., Scholl H.P., Holz F.G. Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. Am. J. Ophthalmol. 2011, 152:695-703.
11. Georgalas I., Tservakis I., Papaconstaninou D., Kardara M., Koutsandrea C., Ladas I. Pseudoxanthoma elasticum, ocular manifestations, complications and treatment. Clin. Exp. Optom. 2011, 94:169-180.
12. Gheduzzi D., Boraldi F., Annovi G., DeVincenzi C.P., Schurgers L.J., Vermeer C., Quaglino D., Ronchetti I.P. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab. Invest. 2007, 87:998-1008.
13. Golub E.E. Biomineralization and matrix vesicles in biology and pathology. Semin. Immunopathol. 2010, 33:409-417.
14. Gorgels T.G., Hu X., Scheffer G.L., van der Wal A.C., Toonstra J., de Jong P.T., van Kuppevelt T.H., Levelt C.N., de Wolf A., Loves W.J., Scheper R.J., Peek R., Bergen A.A. Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum. Mol. Genet. 2005, 14:1763-1773.
15. Gorgels T.G., Waarsing J.H., Herfs M., Versteeg D., Schoensiegel F., Sato T., Schlingemann R.O., Ivandic B., Vermeer C., Schurgers L.J., Bergen A.A. Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum. J. Mol. Med. 2011, 89:1125-1135.
16. Harris B.S., Wang J., Ward-Bailey P.F., Yu H., Bergstrom D.E., Bronson R.T., Donahue L.R. Ages with stiffened joints, a new mutation in Enpp1 2012, The Jackson Laboratory, http://mousemutant.jax.org/articles/mmrmutantasj.html.
17. Heiss A., DuChesne A., Denecke B., Grotzinger J., Yamamoto K., Renne T., Jahnen-Dechent W. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J. Biol. Chem. 2003, 278:13333-13341.
18. Ichikawa S., Imel E.A., Kreiter M.L., Yu X., Mackenzie D.S., Sorenson A.H., Goetz R., Mohammadi M., White K.E., Econs M.J. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 2007, 117:2684-2691.
19. Jahnen-Dechent W., Schinke T., Trindl A., Muller-Esterl W., Sablitzky F., Kaiser S., Blessing M. Cloning and targeted deletion of the mouse fetuin gene. J. Biol. Chem. 1997, 272:31496-31503.
20. -/-). Exp. Dermatol. 2012, 21:694-699.
21. Jiang Q., Endo M., Dibra F., Wang K., Uitto J. Pseudoxanthoma elasticum is a metabolic disease. J. Invest. Dermatol. 2009, 129:348-354.
22. -/-). J. Invest. Dermatol. 2010, 130:1288-1296.
23. -/- mice, a model for pseudoxanthoma elasticum. Cell Cycle 2011, 10:701-707.
24. -/- mice, a model for Pseudoxanthoma elasticum. Matrix Biol. 2012, 31:246-252.
25. Klement J.F., Matsuzaki Y., Jiang Q.J., Terlizzi J., Choi H.Y., Fujimoto N., Li K., Pulkkinen L., Birk D.E., Sundberg J.P., Uitto J. Targeted ablation of the Abcc6 gene results in ectopic mineralization of connective tissues. Mol. Cell. Biol. 2005, 25:8299-8310.
26. -/-). J. Invest. Dermatol. 2009, 129:1388-1394.
27. Le Boulanger G., Labreze C., Croue A., Schurgers L.J., Chassaing N., Wittkampf T., Rutsch F., Martin L. An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am. J. Med. Genet. A 2010, 152A:118-123.
28. Leftheriotis G., Omarjee L., Le Saux O., Henrion D., Abraham P., Prunier F., Willoteaux S., Martin L. The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification. Front. Genet. 2013, 4:4.
29. Li Q., Uitto J. Mineralization/anti-mineralization networks in the skin and vascular connective tissues. Am. J. Pathol 2013, 183:10-18.
30. Li C.F., MacDonald J.R., Wei R.Y., Ray J., Lau K., Kandel C., Koffman R., Bell S., Scherer S.W., Alman B.A. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. BMC Genomics 2007, 8:92-109.
31. Li Q., Jiang Q., Schurgers L.J., Uitto J. Pseudoxanthoma elasticum: reduced gamma-glutamyl carboxylation of matrix gla protein in a mouse model (Abcc6-/-). Biochem. Biophys. Res. Commun. 2007, 364:208-213.
32. -/- mice-potential for treatment of pseudoxanthoma elasticum. Clin. Transl. Sci. 2009, 2:398-404.
33. Li Q., Schurgers L.J., Smith A.C., Tsokos M., Uitto J., Cowen E.W. Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene. Am. J. Pathol. 2009, 174:534-540.
34. Li Q., Schumacher W., Siegel D., Jablonski D., Uitto J. Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene. Br. J. Dermatol. 2012, 166:1107-1111.
35. -/- mice - clinical relevance to pseudoxanthoma elasicum. Am. J. Pathol. 2013, 182:1139-1150.
36. Li Q., Baker J., Kowalczyk J., Jiang Q., Uitto J., Schachner L. Pediatric pseudoxanthoma elasticum with cardiovascular involvement. Br. J. Dermatol. 2013, (Epub ahead of print, PMID:23746227).
37. Li Q., Guo H., Chou D.W., Berndt A., Sundberg J.P., Uitto J. Mutant Enpp1asj mouse as a model for generalized arterial calcification of infancy. Dis. Model. Mech. 2013, (Epub ahead of print, PMID:23798568).
38. Li Q., Brodsky J.L., Conlin L., Pawel B., Glatz A., Gafni R.I., Schurgers L.J., Uitto J., Hakonarson H., Deardoff M.A., Levine M. Mutations in the ABCC6 gene as a cause of generalized arterial calcification of infancy - genotypic overlap with pseudoxanthoma elasticum 2013, JID (in press).
39. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
40. -/- mice. PLoS One 2012, 7:e32177.
41. Markello T.C., Pak L.K., St Hilaire C., Dorward H., Ziegler S.G., Chen M.Y., Chaganti K., Nussbaum R.L., Boehm M., Gahl W.A. Vascular pathology of medial arterial calcifications in NT5E deficiency: Implications for the role of adenosine in pseudoxanthoma elasticum. Mol. Genet. Metab. 2011, 103:44-50.
42. Mornet E. Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene. Hum. Mutat. 2000, 15:309-315.
43. Neldner K.H. Pseudoxanthoma elasticum. Clin. Dermatol. 1988, 6:1-159.
44. Ng A.T., Peng D.H. Calciphylaxis. Dermatol. Ther. 2011, 24:256-262.
45. Nitschke Y., Rutsch F. Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin. Front. Genet. 2012, 3:302.
46. Nitschke Y., Rutsch F. Genetics in arterial calcification: lessons learned from rare diseases. Trends Cardiovasc. Med. 2012, 22:145-149.
47. Nitschke Y., Baujat G., Botschen U., Wittkampf T., du Moulin M., Stella J., Le Merrer M., Guest G., Lambot K., Tazarourte-Pinturier M.F., Chassaing N., Roche O., Feenstra I., Loechner K., Deshpande C., Garber S.J., Chikarmane R., Steinmann B., Shahinyan T., Martorell L., Davies J., Smith W.E., Kahler S.G., McCulloch M., Wraige E., Loidi L., Hohne W., Martin L., Hadj-Rabia S., Terkeltaub R., Rutsch F. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am. J. Hum. Genet. 2012, 90:25-39.
48. Pfendner E.G., Vanakker O.M., Terry S.F., Vourthis S., McAndrew P.E., McClain M.R., Fratta S., Marais A.S., Hariri S., Coucke P.J., Ramsay M., Viljoen D., Terry P.F., De Paepe A., Uitto J., Bercovitch L.G. Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J. Med. Genet. 2007, 44:621-628.
49. Pomozi V., Le Saux O., Brampton C., Apana A., Ilias A., Szeri F., Martin L., Monostory K., Paku S., Sarkadi B., Szakacs G., Varadi A. ABCC6 Is a Basolateral Plasma Membrane Protein. Circ. Res. 2013, 112:e148-e151.
50. Ralston S.H. Clinical practice. Paget's disease of bone. N. Engl. J. Med. 2013, 368:644-650.
51. Rutsch F., Ruf N., Vaingankar S., Toliat M.R., Suk A., Hohne W., Schauer G., Lehmann M., Roscioli T., Schnabel D., Epplen J.T., Knisely A., Superti-Furga A., McGill J., Filippone M., Sinaiko A.R., Vallance H., Hinrichs B., Smith W., Ferre M., Terkeltaub R., Nurnberg P. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat. Genet. 2003, 34:379-381.
52. Rutsch F., Boyer P., Nitschke Y., Ruf N., Lorenz-Depierieux B., Wittkampf T., Weissen-Plenz G., Fischer R.J., Mughal Z., Gregory J.W., Davies J.H., Loirat C., Strom T.M., Schnabel D., Nurnberg P., Terkeltaub R. Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ. Cardiovasc. Genet. 2008, 1:133-140.
53. Rutsch F., Nitschke Y., Terkeltaub R. Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ. Res. 2011, 109:578-592.
54. Schurgers L.J., Uitto J., Reutelingsperger C.P. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol. Med. 2013, 19:217-226.
55. Sprecher E. Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. J. Invest. Dermatol. 2010, 130:652-660.
56. St Hilaire C., Ziegler S.G., Markello T.C., Brusco A., Groden C., Gill F., Carlson-Donohoe H., Lederman R.J., Chen M.Y., Yang D., Siegenthaler M.P., Arduino C., Mancini C., Freudenthal B., Stanescu H.C., Zdebik A.A., Chaganti R.K., Nussbaum R.L., Kleta R., Gahl W.A., Boehm M. NT5E mutations and arterial calcifications. N. Engl. J. Med. 2011, 364:432-442.
57. Thouverey C., Strzelecka-Kiliszek A., Balcerzak M., Buchet R., Pikula S. Matrix vesicles originate from apical membrane microvilli of mineralizing osteoblast-like Saos-2 cells. J. Cell. Biochem. 2009, 106:127-138.
58. Topaz O., Shurman D.L., Bergman R., Indelman M., Ratajczak P., Mizrachi M., Khamaysi Z., Behar D., Petronius D., Friedman V., Zelikovic I., Raimer S., Metzker A., Richard G., Sprecher E. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat. Genet. 2004, 36:579-581.
59. Topaz O., Indelman M., Chefetz I., Geiger D., Metzker A., Altschuler Y., Choder M., Bercovich D., Uitto J., Bergman R., Richard G., Sprecher E. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am. J. Hum. Genet. 2006, 79:759-764.
60. Uitto J., Li Q., Jiang Q. Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms. J. Invest. Dermatol. 2010, 130:661-670.
61. Uitto J., Varadi A., Bercovitch L., Terry P.F., Terry S.F. Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE International Research Meeting. J. Invest. Dermatol. 2013, 133:1444-1449.
62. Vanakker O.M., Martin L., Gheduzzi D., Leroy B.P., Loeys B.L., Guerci V.I., Matthys D., Terry S.F., Coucke P.J., Pasquali-Ronchetti I., De Paepe A. Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J. Invest. Dermatol. 2007, 127:581-587.
63. Wang W., Xu J., Du B., Kirsch T. Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol. Cell. Biol. 2005, 25:312-323.
64. Warriner A.H., Saag K.G. Osteoporosis diagnosis and medical treatment. Orthop. Clin. N. Am. 2013, 44:125-135.
65. Zebardast N., Adelman R.A. Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-up. Semin. Ophthalmol. 2012, 27:61-64.